[HTML][HTML] New versus old: the impact of changing patterns of inhaled corticosteroid prescribing and dosing regimens in asthma management
D Singh, G Garcia, K Maneechotesuwan… - Advances in …, 2022 - Springer
Inhaled corticosteroid (ICS)-containing therapies are the mainstay of pharmacological
management of asthma. They can be administered alone or in combination with a long …
management of asthma. They can be administered alone or in combination with a long …
[HTML][HTML] Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled …
F Maltais, L Bjermer, EM Kerwin, PW Jones… - Respiratory …, 2019 - Springer
Background Prospective evidence is lacking regarding incremental benefits of long-acting
dual-versus mono-bronchodilation in improving symptoms and preventing short-term …
dual-versus mono-bronchodilation in improving symptoms and preventing short-term …
Defining the “frequent exacerbator” phenotype in COPD: a hypothesis-free approach
O Le Rouzic, N Roche, AB Cortot, I Tillie-Leblond… - Chest, 2018 - Elsevier
Background The COPD “frequent exacerbator” phenotype is usually defined by at least two
treated exacerbations per year and is associated with a huge impact on patient health …
treated exacerbations per year and is associated with a huge impact on patient health …
Annual direct medical cost of active systemic lupus erythematosus in five European countries
Objectives To evaluate the annual direct medical cost of managing adult systemic lupus
erythematosus (SLE) patients with active autoantibody positive disease in Europe. Methods …
erythematosus (SLE) patients with active autoantibody positive disease in Europe. Methods …
Future concepts in bronchodilation for COPD: dual-versus monotherapy
D Singh, JF Donohue, IH Boucot… - European …, 2021 - Eur Respiratory Soc
Most patients with COPD are recommended to initiate maintenance therapy with a single
long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β2 …
long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β2 …
[HTML][HTML] Control of asthma in children: still unacceptable? A French cross-sectional study
J de Blic, I Boucot, C Pribil, J Robert, D Huas… - Respiratory …, 2009 - Elsevier
BACKGROUND: The goal of asthma management focuses on adequate control of asthma,
although little is known about the optimal level of asthma control to be reached. The ELIOS …
although little is known about the optimal level of asthma control to be reached. The ELIOS …
Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children
P Gehanno, G Lenoir, B Barry, J Bons… - The Pediatric …, 1996 - journals.lww.com
Background The recent emergence of penicillin-resistant Streptococcus pneumoniae,
particularly in acute otitis media (AOM), has increased interest in the development of …
particularly in acute otitis media (AOM), has increased interest in the development of …
[HTML][HTML] Primary care management of asthma exacerbations or attacks: impact of the COVID-19 pandemic
M Fletcher, T van der Molen, W Lenney, I Boucot… - Advances in …, 2022 - Springer
The COVID-19 pandemic has brought a renewed focus on appropriate management of
chronic respiratory conditions with a heightened awareness of respiratory symptoms and the …
chronic respiratory conditions with a heightened awareness of respiratory symptoms and the …
Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability
A Woodcock, I Boucot, DA Leather… - European …, 2018 - Eur Respiratory Soc
Guidelines for chronic obstructive pulmonary disease (COPD) management are based
largely on results from double-blind randomised controlled trials (RCTs) of efficacy. These …
largely on results from double-blind randomised controlled trials (RCTs) of efficacy. These …
Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children
Y Aujard, I Boucot, N Brahimi, D Chiche… - The Pediatric …, 1995 - journals.lww.com
In a prospective randomized multicenter study, 308 children, ages 2 to 15 years, were
randomized to receive either cefuroxime axetil suspension (N= 152; 20 mg/kg/day twice …
randomized to receive either cefuroxime axetil suspension (N= 152; 20 mg/kg/day twice …